Browse
related articles
Second Pan-Arab Continence Society Congress set to meet in Dubai in December of 2005
- United Arab Emirates: Wednesday, March 30 - 2005 at 13:14
- PRESS RELEASE
Prominent physicians and medical school professors convened this week in Dubai to set the groundwork for a constructive program of international level continuing medical education, to include an annual conference, that is expected to dramatically raise the Middle East medical community's awareness about new treatments in the area of urinary incontinence, or overactive bladder, a condition which is believed to affect one in three men and half of all women in the Middle East, according to physicians with the newly-formed Pan-Arab Continence Society (PACS).
"Millions of Arabs suffer from some degree of overactive bladder, but they 'suffer in silence' and fail to seek medical treatment for their condition," said Professor M. Sherif Mourad, M.D., President of PACS, and chief organizer of the groups.
"The goal of PACS, therefore, is to raise the level of awareness about suitable medical treatments, and this awareness must begin with doctors before it can be fully and effectively communicated to patients," added Mourad.
Members of the PACS' board of directors met recently in Dubai to agree the annual congress' agenda and establish its scientific program. These medical doctors include: Adel Honayan of Kuwait; Ahmed El Badr of Saudi Arabia; Ayman El Qatawneh of Jordan; Awatef El Bahr and Nabil Metry of UAE; Marwan El Khani of Syria; Nimat Saigh of Iraq; and Mohamed Bolbol and Michel Jabbour of Lebanon.
PACS honorary board members include professors: Linda Cardozo and Paul Abrams of the United Kingdom; Mohamed Ghoneim of Egypt; Mostafa El Hilali of Canada; Philip Van Kerrebroeck of Netherlands; and Walter Artibani of Italy.
The International Continence Society Annual Congress will take place in Montreal in 2005, but has already been scheduled for Cairo in 2008.
Also consider reading:
Browse
related articles
- » Abu Dhabi to 'pick and choose' Dubai support
- » Samsung halts Dubai bridge work amidst Dubai debt crisis
- » Moody's: UAE banks with largest exposures to Dubai World remain on review
- » Emirate of Abu Dhabi 'AA/A-1+' sovereign ratings affirmed; outlook stable
- » Fitch downgrades Dubai Bank, Tamweel and TAIB Bank on Dubai World restructuring proposal
Notes and media contacts
About PfizerPfizer Inc discovers, develops, manufactures and markets leading prescription medicines, for humans and animals, as well as many of the world's best-known consumer products.
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
Posted by Anne-Birte Stensgaard, Senior News Editor
